Morgan Stanley Forte Biosciences, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

Shares

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Oct 17, 2024	BUY	$0.46 - $0.78 $1,292 - $2,191	2,810 Added 282.7%	3,804 $2,000
Q2 2024 Aug 14, 2024	BUY	$0.46 - $0.78 $1,292 - $2,191	2,810 Added 282.7%	3,804 $2,000
Q1 2024 Oct 17, 2024	SELL	$0.48 - $0.85 $1,348 - $2,388	-2,810 Reduced 73.87%	994 $0
Q4 2023 Aug 16, 2024	SELL	$0.38 - $0.82 $1,067 - $2,304	-2,810 Reduced 73.87%	994 $0
Q2 2023 Aug 14, 2023	SELL	$0.98 - $1.11 $109 - $124	-112 Reduced 10.13%	994 $1,000
Q1 2023 May 15, 2023	SELL	$0.98 - $1.06 $306 - $331	-313 Reduced 22.06%	1,106 $1,000
Q4 2022 Feb 14, 2023	BUY	$0.96 - $28.0 $13 - $392	14 Added 1.0%	1,419 $1,000
Q3 2022 Nov 14, 2022	SELL	$1.06 - $27.75 $355,772 - $9.31 Million	-335,634 Reduced 99.58%	1,405 $1,000
Q2 2022 Oct 27, 2022	SELL	$1.07 - $1.55 $107,172 - $155,249	-100,161 Reduced 22.91%	337,039 $438,000
Q2 2022 Aug 15, 2022	SELL	$1.07 - $1.55 $107,172 - $155,249	-100,161 Reduced 22.91%	337,039 $438,000
Q1 2022 Oct 27, 2022	BUY	$1.21 - $2.24 $121,194 - $224,360	100,161 Added 29.72%	437,200 $637,000
Q1 2022 May 13, 2022	SELL	$1.21 - $2.24 $815,725 - $1.51 Million	-674,153 Reduced 60.66%	437,200 $637,000
Q4 2021 Feb 14, 2022	BUY	$2.02 - $3.36 $2.23 Million - $3.7 Million	1,101,718 Added 11434.54%	1,111,353 $2.38 Million
Q3 2021 Nov 15, 2021	BUY	$2.96 - $36.67 $28,519 - $353,315	9,635 New	9,635 $28,000

Others Institutions Holding FBRX

# of Institutions

1

Shares Held

175K

Call Options Held

0

Put Options Held

0

Black Rock Inc. New York, NY

175K
Shares

$3.19 Million
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $371M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.